Stay updated on SAR442168 Dose-finding in MS Clinical Trial

Sign up to get notified when there's something new on the SAR442168 Dose-finding in MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAR442168 Dose-finding in MS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record now presents details for Sanofi’s completed Phase 2b SAR442168 dose-finding study in relapsing multiple sclerosis, including its design, outcomes, eligibility criteria, locations, and results-related documents.
    Difference
    84%
    Check dated 2026-11-07T12:47:57.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:37:06.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the error page, announcing transition updates and explaining that NIH content may use “Super Intelligence” alongside “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T13:08:24.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:22:25.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the page displaying a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:10:50.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the usual study details with an error screen.
    Difference
    20%
    Check dated 2026-09-19T19:25:41.000Z thumbnail image

Stay in the know with updates to SAR442168 Dose-finding in MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAR442168 Dose-finding in MS Clinical Trial page.